Moderate
Suspected
설명
Carbamazepine may reduce levodopa efficacy through enzyme induction and pharmacodynamic antagonism, potentially worsening Parkinson's disease control.
기전
Carbamazepine induces hepatic enzymes that metabolize levodopa's carbidopa component, potentially increasing peripheral levodopa breakdown; it may also block dopaminergic effects centrally.
임상적 중요성
Worsening motor function has been reported in Parkinson's patients starting carbamazepine; tremor and rigidity may increase.
관리 방법
Monitor motor function closely; levodopa dose increase may be needed; consider alternative anticonvulsants (lamotrigine, gabapentin).